SCHEMBL6992052

SCHEMBL6992052

NC(=O)c1cccc(-c2ccc(C=C3SC(=O)NC3=O)cc2)c1Cc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 3/20 0.50
HPGD P15428 12/20 0.49
PIM1 P11309 1/20 0.49
PIM3 Q86V86 1/20 0.49
PIM2 Q9P1W9 1/20 0.49
MAOA P21397 2/20 0.47
MAOB P27338 2/20 0.47
POLB P06746 1/20 0.47
GSK3B P49841 1/20 0.44
ALOX12 P18054 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6992046 1.00 PTPN1 (0.50) PTPN1HPGDPIM1PIM3PIM2
SCHEMBL6992056 0.75 PTPN1 (0.51) PTPN1HPGDPIM1PIM3PIM2
SCHEMBL1248780 0.71 PIM1 (0.83) PTPN1HPGDPIM1PIM3PIM2
SCHEMBL1248782 0.71 PIM1 (0.83) PTPN1HPGDPIM1PIM3PIM2
SCHEMBL12891790 0.71 PIM1 (0.83) PTPN1HPGDPIM1PIM3PIM2
SCHEMBL6183585 0.69 MEN1 (0.60) HPGDPIM1PIM3PIM2MAOA
SCHEMBL6183587 0.69 MEN1 (0.60) HPGDPIM1PIM3PIM2MAOA
SCHEMBL4206382 0.69 PIM1 (0.64) HPGDPIM1PIM3PIM2MAOA
SCHEMBL4035316 0.69 PIM1 (0.64) HPGDPIM1PIM3PIM2MAOA
SCHEMBL4035319 0.69 PIM1 (0.64) HPGDPIM1PIM3PIM2MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1309575-A1 BIPHENYL DERIVATIVES AND THEIR USE AS PPAR-GAMMA RECEPTOR ACTIVATORS Galderma Research & Development (FR) 2003-05-14 EP disclosed
WO-2002012210-A9 BIPHENYL DERIVATIVES AND THEIR USE AS PPAR-GAMMA RECEPTOR ACTIVATORS GALDERMA RES & DEV (FR) 2002-04-18 WO disclosed
WO-2002012210-A1 BIPHENYL DERIVATIVES AND THEIR USE AS PPAR-GAMMA RECEPTOR ACTIVATORS GALDERMA RESEARCH & DEVELOPMENT (FR) 2002-02-14 WO disclosed